PI
CRBP icon

PEAK6 Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

PEAK6 Investments’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-140
Closed -$29K – 3755
2019
Q1 		$29K Buy
140
+66
+89% +$14.6K ﹤0.01% 3516
2018
Q4 		$13K Sell
74
-426
-85% -$85K ﹤0.01% 3816
2018
Q3 		$113K Buy
+500
New +$80.8K ﹤0.01% 3486

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PEAK6 Investments's CRBP Position: Q2 2019 in Review

PEAK6 Investments sold out of Corbus Pharmaceuticals (CRBP) in Q2 2019, closing a stake of 140 shares — an estimated $29K sold.

PEAK6 Investments first reported a position in CRBP in Q3 2018 and held it in 3 quarters. The position peaked at $113K in Q3 2018. 103 funds tracked by Wall St. Rank hold CRBP as of Q2 2019.

  • PEAK6 Investments reported no remaining Corbus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • PEAK6 Investments sold 140 Corbus Pharmaceuticals shares in Q2 2019, an estimated $29K.
  • PEAK6 Investments first reported a position in Corbus Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • PEAK6 Investments's Corbus Pharmaceuticals position peaked at $113K in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2019.

Based on PEAK6 Investments's 13F filing for Q2 2019, filed 14 Aug 2019.